Signal Transduction and Targeted Therapy (Jul 2021)

Differential immune responses in pregnant patients recovered from COVID-19

  • Ge Chen,
  • Yiming Zhang,
  • Yaoyao Zhang,
  • Jihui Ai,
  • Bin Yang,
  • Mengge Cui,
  • Qiuyue Liao,
  • Hanxiao Chen,
  • Hualin Bai,
  • Dashing Shang,
  • Jing Chen,
  • ChaoYang Sun,
  • Haiyi Liu,
  • Fengyuan Liu,
  • Bin Mao,
  • Guoqiang Sun,
  • Lu Chen,
  • Jing-wen Lin,
  • Kezhen Li

DOI
https://doi.org/10.1038/s41392-021-00703-3
Journal volume & issue
Vol. 6, no. 1
pp. 1 – 15

Abstract

Read online

Abstract Pregnant women are generally more susceptible to viral infection. Although the impact of SARS-CoV-2 in pregnancy remains to be determined, evidence indicates that the risk factors for severe COVID-19 are similar in pregnancy to the general population. Here we systemically analyzed the clinical characteristics of pregnant and non-pregnant female COVID-19 patients who were hospitalized during the same period and found that pregnant patients developed marked lymphopenia and higher inflammation evident by higher C-reactive protein and IL-6. To elucidate the pathways that might contribute to immunopathology or protective immunity against COVID-19 during pregnancy, we applied single-cell mRNA sequencing to profile peripheral blood mononuclear cells from four pregnant and six non-pregnant female patients after recovery along with four pregnant and three non-pregnant healthy donors. We found normal clonal expansion of T cells in the pregnant patients, heightened activation and chemotaxis in NK, NKT, and MAIT cells, and differential interferon responses in the monocyte compartment. Our data present a unique feature in both innate and adaptive immune responses in pregnant patients recovered from COVID-19.